Annual Operating Profit
-$33.92 M
-$4.02 M-13.43%
December 31, 2023
Summary
- As of February 6, 2025, TRVI annual operating income is -$33.92 million, with the most recent change of -$4.02 million (-13.43%) on December 31, 2023.
- During the last 3 years, TRVI annual operating profit has fallen by -$1.43 million (-4.41%).
- TRVI annual operating profit is now -311.84% below its all-time high of -$8.24 million, reached on December 31, 2017.
Performance
TRVI Operating Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Operating Profit
-$14.09 M
-$798.00 K-6.00%
September 30, 2024
Summary
- As of February 6, 2025, TRVI quarterly operating income is -$14.09 million, with the most recent change of -$798.00 thousand (-6.00%) on September 30, 2024.
- Over the past year, TRVI quarterly operating profit has dropped by -$5.15 million (-57.70%).
- TRVI quarterly operating profit is now -348.35% below its all-time high of -$3.14 million, reached on March 31, 2018.
Performance
TRVI Quarterly Operating Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM Operating Profit
-$48.22 M
-$5.04 M-11.68%
September 30, 2024
Summary
- As of February 6, 2025, TRVI TTM operating income is -$48.22 million, with the most recent change of -$5.04 million (-11.68%) on September 30, 2024.
- Over the past year, TRVI TTM operating profit has dropped by -$14.29 million (-42.13%).
- TRVI TTM operating profit is now -1434.53% below its all-time high of -$3.14 million, reached on March 31, 2018.
Performance
TRVI TTM Operating Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Operating Profit Formula
Operating Profit = Gross Profit − Operating Expenses
TRVI Operating Profit Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -13.4% | -57.7% | -42.1% |
| 3 y3 years | -4.4% | -102.8% | -44.4% |
| 5 y5 years | -84.3% | -84.1% | -81.0% |
TRVI Operating Profit Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -13.4% | at low | -111.6% | at low | -61.2% | at low |
| 5 y | 5-year | -27.3% | at low | -111.6% | at low | -81.0% | at low |
| alltime | all time | -311.8% | at low | -348.4% | at low | -1434.5% | at low |
Trevi Therapeutics Operating Profit History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | -$14.09 M(+6.0%) | -$48.22 M(+11.7%) |
| Jun 2024 | - | -$13.29 M(+11.6%) | -$43.17 M(+12.8%) |
| Mar 2024 | - | -$11.91 M(+33.3%) | -$38.27 M(+12.8%) |
| Dec 2023 | -$33.92 M(+13.4%) | -$8.93 M(-1.2%) | -$33.92 M(+7.2%) |
| Sep 2023 | - | -$9.04 M(+7.9%) | -$31.65 M(+2.1%) |
| Jun 2023 | - | -$8.38 M(+10.8%) | -$31.01 M(+1.8%) |
| Mar 2023 | - | -$7.56 M(+13.6%) | -$30.45 M(+1.8%) |
| Dec 2022 | -$29.91 M(-7.9%) | -$6.66 M(-20.8%) | -$29.91 M(-5.1%) |
| Sep 2022 | - | -$8.40 M(+7.5%) | -$31.52 M(+4.8%) |
| Jun 2022 | - | -$7.82 M(+11.3%) | -$30.07 M(-4.3%) |
| Mar 2022 | - | -$7.03 M(-15.1%) | -$31.41 M(-3.3%) |
| Dec 2021 | -$32.48 M | -$8.27 M(+19.1%) | -$32.48 M(-2.8%) |
| Sep 2021 | - | -$6.95 M(-24.2%) | -$33.40 M(-0.9%) |
| Jun 2021 | - | -$9.17 M(+13.3%) | -$33.69 M(+5.5%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2021 | - | -$8.09 M(-12.0%) | -$31.94 M(-1.7%) |
| Dec 2020 | -$32.49 M(+21.9%) | -$9.19 M(+26.9%) | -$32.49 M(+8.1%) |
| Sep 2020 | - | -$7.24 M(-2.3%) | -$30.06 M(-1.3%) |
| Jun 2020 | - | -$7.41 M(-14.2%) | -$30.47 M(-0.0%) |
| Mar 2020 | - | -$8.64 M(+27.7%) | -$30.47 M(+14.4%) |
| Dec 2019 | -$26.64 M(+44.7%) | -$6.77 M(-11.6%) | -$26.64 M(+3.2%) |
| Sep 2019 | - | -$7.65 M(+3.1%) | -$25.81 M(+11.7%) |
| Jun 2019 | - | -$7.42 M(+54.1%) | -$23.11 M(+15.1%) |
| Mar 2019 | - | -$4.81 M(-18.8%) | -$20.08 M(+9.1%) |
| Dec 2018 | -$18.41 M(+123.5%) | -$5.93 M(+19.6%) | -$18.41 M(+47.5%) |
| Sep 2018 | - | -$4.96 M(+13.2%) | -$12.48 M(+65.9%) |
| Jun 2018 | - | -$4.38 M(+39.4%) | -$7.52 M(+139.4%) |
| Mar 2018 | - | -$3.14 M | -$3.14 M |
| Dec 2017 | -$8.24 M | - | - |
FAQ
- What is Trevi Therapeutics annual operating income?
- What is the all time high annual operating profit for Trevi Therapeutics?
- What is Trevi Therapeutics annual operating profit year-on-year change?
- What is Trevi Therapeutics quarterly operating income?
- What is the all time high quarterly operating profit for Trevi Therapeutics?
- What is Trevi Therapeutics quarterly operating profit year-on-year change?
- What is Trevi Therapeutics TTM operating income?
- What is the all time high TTM operating profit for Trevi Therapeutics?
- What is Trevi Therapeutics TTM operating profit year-on-year change?
What is Trevi Therapeutics annual operating income?
The current annual operating profit of TRVI is -$33.92 M
What is the all time high annual operating profit for Trevi Therapeutics?
Trevi Therapeutics all-time high annual operating income is -$8.24 M
What is Trevi Therapeutics annual operating profit year-on-year change?
Over the past year, TRVI annual operating income has changed by -$4.02 M (-13.43%)
What is Trevi Therapeutics quarterly operating income?
The current quarterly operating profit of TRVI is -$14.09 M
What is the all time high quarterly operating profit for Trevi Therapeutics?
Trevi Therapeutics all-time high quarterly operating income is -$3.14 M
What is Trevi Therapeutics quarterly operating profit year-on-year change?
Over the past year, TRVI quarterly operating income has changed by -$5.15 M (-57.70%)
What is Trevi Therapeutics TTM operating income?
The current TTM operating profit of TRVI is -$48.22 M
What is the all time high TTM operating profit for Trevi Therapeutics?
Trevi Therapeutics all-time high TTM operating income is -$3.14 M
What is Trevi Therapeutics TTM operating profit year-on-year change?
Over the past year, TRVI TTM operating income has changed by -$14.29 M (-42.13%)